RAILY AESMED Reports Stable Share Capital in May 2026; 8.49% Potential Dilution from Outstanding Options

Bulletin Express

Jun 03

On 3 June 2026, Raily Aesthetic Medicine International Holdings Limited (RAILY AESMED) filed its monthly return for the period ended 31 May 2026, showing no changes in share capital structure.

The authorised share capital remained at 1 billion ordinary shares with a par value of USD 0.05, equivalent to USD 50.00 million.

Issued shares were unchanged at 557.08 million, and the company continued to hold no treasury shares. RAILY AESMED confirmed compliance with the Hong Kong Stock Exchange’s 25% public-float requirement.

Under the share-option scheme adopted on 4 December 2020, 47.28 million options were outstanding at month-end, representing a potential dilution of approximately 8.49% of the existing share base if fully exercised. No options were exercised, and no funds were raised during the month.

The filing indicated no warrants, convertible securities, or other equity arrangements, and the company secretary, Chan Oi Fat, affirmed full adherence to all applicable listing and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1190872546"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190872546\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190872546?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 16:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190872546","market":"hk","top_or_hot":-1,"title":"RAILY AESMED Reports Stable Share Capital in May 2026; 8.49% Potential Dilution from Outstanding Options","media":"Bulletin Express","content":"<p>On 3 June 2026, Raily Aesthetic Medicine International Holdings Limited (RAILY AESMED) filed its monthly return for the period ended 31 May 2026, showing no changes in share capital structure.</p>\n<p>The authorised share capital remained at 1 billion ordinary shares with a par value of USD 0.05, equivalent to USD 50.00 million.</p>\n<p>Issued shares were unchanged at 557.08 million, and the company continued to hold no treasury shares. RAILY AESMED confirmed compliance with the Hong Kong Stock Exchange’s 25% public-float requirement.</p>\n<p>Under the share-option scheme adopted on 4 December 2020, 47.28 million options were outstanding at month-end, representing a potential dilution of approximately 8.49% of the existing share base if fully exercised. No options were exercised, and no funds were raised during the month.</p>\n<p>The filing indicated no warrants, convertible securities, or other equity arrangements, and the company secretary, Chan Oi Fat, affirmed full adherence to all applicable listing and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RAILY AESMED Reports Stable Share Capital in May 2026; 8.49% Potential Dilution from Outstanding Options</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRAILY AESMED Reports Stable Share Capital in May 2026; 8.49% Potential Dilution from Outstanding Options\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 16:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 3 June 2026, Raily Aesthetic Medicine International Holdings Limited (RAILY AESMED) filed its monthly return for the period ended 31 May 2026, showing no changes in share capital structure.</p>\n<p>The authorised share capital remained at 1 billion ordinary shares with a par value of USD 0.05, equivalent to USD 50.00 million.</p>\n<p>Issued shares were unchanged at 557.08 million, and the company continued to hold no treasury shares. RAILY AESMED confirmed compliance with the Hong Kong Stock Exchange’s 25% public-float requirement.</p>\n<p>Under the share-option scheme adopted on 4 December 2020, 47.28 million options were outstanding at month-end, representing a potential dilution of approximately 8.49% of the existing share base if fully exercised. No options were exercised, and no funds were raised during the month.</p>\n<p>The filing indicated no warrants, convertible securities, or other equity arrangements, and the company secretary, Chan Oi Fat, affirmed full adherence to all applicable listing and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02135","symbol_name":"瑞丽医美","start_time":0,"source_url":"","article_id":"1190872546","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190872546","pubTimestamp":1780474989,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 3 June 2026, Raily Aesthetic Medicine International Holdings Limited (RAILY AESMED) filed its monthly return for the period ended 31 May 2026, showing no changes in share capital structure. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02135":"瑞丽医美"},"translate_title":"RAILY AESMED报告2026年5月股本稳定；未行使期权可能稀释8.49%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02135":1},"content_text":"On 3 June 2026, Raily Aesthetic Medicine International Holdings Limited (RAILY AESMED) filed its monthly return for the period ended 31 May 2026, showing no changes in share capital structure.\nThe authorised share capital remained at 1 billion ordinary shares with a par value of USD 0.05, equivalent to USD 50.00 million.\nIssued shares were unchanged at 557.08 million, and the company continued to hold no treasury shares. RAILY AESMED confirmed compliance with the Hong Kong Stock Exchange’s 25% public-float requirement.\nUnder the share-option scheme adopted on 4 December 2020, 47.28 million options were outstanding at month-end, representing a potential dilution of approximately 8.49% of the existing share base if fully exercised. No options were exercised, and no funds were raised during the month.\nThe filing indicated no warrants, convertible securities, or other equity arrangements, and the company secretary, Chan Oi Fat, affirmed full adherence to all applicable listing and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}